MedPath

A clinical trial to study effect of kushmanda churna in children with epilepsy.

Phase 1
Not yet recruiting
Conditions
Health Condition 1: G409- Epilepsy, unspecified
Registration Number
CTRI/2024/04/065882
Lead Sponsor
KLE Ayurveda Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients from either sex in age group between 5-16 years.

Patients fulfilling the diagnostic criteria will be included for the study.

Epilepsy of any origin.

Patients on conventional antiepileptic therapy.

Exclusion Criteria

Patients with any life-threatening congenital anomalies like congenital heart disease (CHD)

etc. will be excluded.

Patients with other disease status like Acute infections, severe systemic illness etc. will be.

excluded from the study.

Patients with severe debilitating illnesses like mental retardation, spastic quadriplegia etc.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
There might be significant effect of Kushmand churna in children <br/ ><br>with conventional antiepileptic therapy.Timepoint: 0 day <br/ ><br>30 days <br/ ><br>60 days
Secondary Outcome Measures
NameTimeMethod
Quality of Life in Childhood Epilepsy Questionnaire <br/ ><br>Global assessment of the severity of epilepsy Scale <br/ ><br>THE NATIONAL HOSPITAL SEIZURE SEVERITY SCALETimepoint: 0 day <br/ ><br>30th day <br/ ><br>60th day
Âİ Copyright 2025. All Rights Reserved by MedPath